Lu Wang
Dr. Lu Wang is an early-career breast cancer genomic scientist in QIMR. She focuses on understanding how the noncoding genome modulates breast cancer development, with the ultimate goal of identifying novel therapeutic targets. She completed her Ph.D. at QIMR with Queensland University of Technology in 2023. She was awarded ACRF Prize for Cancer Research Excellence 2025. Dr. Wang has expertise in non-coding RNA biology, developing 2D/3D CRISPR–Cas13 systems and CROP-seq platforms to uncover regulatory networks driving breast cancer progression.
Abstracts this author is presenting:
